Compliance & Regulations

Japan's 2026 cannabinoid
regulatory landscape.

The rules have changed. Ingredient-based regulation, THC residue limits, and the active CBN designation process create new risks — and clear opportunities — for brands entering correctly.

⚠ CBN (Cannabinol) — Designation Process OngoingJapan's Pharmaceutical & Food Safety Council ruled designation "appropriate" (Oct 2025). Feb 2026 notice delayed — but designation intent unchanged. Treat CBN as prohibited.
⚠ THC Residue Limits — In Force Dec 12, 2024Oils & powders ≤ 10 ppm ・ Water-based products ≤ 0.1 ppm ・ All other products ≤ 1 ppm

04 — Compliance Reference

2026 Compliance
Quick Reference

✕ Prohibited
Δ9-THC above the product-category residue limits
CBN (Cannabinol) — designation process active; treat as import-prohibited
Broad-spectrum products with detectable CBN contamination
Any product without a Japan-accredited lab CoA
Importing without MHLW notification or approval
⚠ Requires Verification
Full-spectrum CBD oil — must confirm THC ≤ 10 ppm and CBN not detected
Broad-spectrum CBD — CBN contamination risk; re-testing mandatory
Water-soluble / beverage CBD — stricter 0.1 ppm limit applies (not 10 ppm)
Capsules & gummies — 1 ppm limit; confirm product category classification
CBG & CBC — currently unscheduled but informally monitored by MHLW
✓ Clear Pathway Exists
CBD isolate products — lowest CBN contamination risk; simplest compliance path
Broad-spectrum with Japan-accredited "CBN not detected" confirmation
CBG products — currently unscheduled; best positioned post-CBN
Terpene-forward CBD — wellness positioning, low regulatory risk
CBD topicals & cosmetics — separate regulatory pathway, lower barrier
Product CategoryLegal LimitEquivalentNotes
Oils & Powders≤ 10 ppm10 mg/kgStandard CBD oils, tinctures
Water-based & Water-soluble≤ 0.1 ppm0.10 mg/kg100× stricter — most commonly missed
Other (capsules, gummies, topicals)≤ 1 ppm1 mg/kgMost edibles, soft gels, and topicals

01 — Regulatory Landscape

Japan Cannabinoid
Regulatory Timeline

2013

Japan's First CBD Import Approval

Asayake Inc. negotiated directly with MHLW and secured Japan's first-ever CBD product import approval — building the customs pathway from scratch when no framework existed.

December 12, 2024 — In Force

Cannabis Control Act Reform — Ingredient-Based Regulation

Japan shifted from plant-part regulation to ingredient-based regulation. Products with Δ9-THC ≤ 0.3% are legally defined as CBD products. Product-category THC residue limits simultaneously enacted.

March 1, 2025 — In Force

Phase 2 — Cultivation Licensing System

New cultivation permit categories introduced. THC possession penalties increased from 5 to 7 years.

October 2025 → Notice Date: TBD

CBN Designation Process — Ongoing

Following a May 2025 incident in Yamanashi, MHLW initiated psychotoxicity review of CBN. Council ruled designation "appropriate" in October. February 2026 notice was delayed — but designation intent has not been withdrawn.

Outlook

Further Cannabinoid Scheduling Expected

CBG and CBC are currently unscheduled. Japan's regulatory pace has accelerated significantly since 2024. Brands should expect continued scrutiny of novel cannabinoids.

※ As of March 2026

CBN's formal enactment date is unconfirmed, but MHLW has not withdrawn its designation intent. Treat CBN as effectively prohibited and move to alternative cannabinoids without delay.

Is your product affected?

Get a formal written answer from Japanese authorities before committing capital to a Japan market entry. That's exactly what Import Verdict™ delivers.

Import Verdict™ ¥55,000

Is your product affected?

Get the official written verdict.

Import Verdict™ delivers a formal written report from Japanese authorities stating your product's importability — before you ship a single unit.

★ Import Verdict™ — From ¥55,000